Skip to main content

Advertisement

Log in

Multiple intracranial melanoma metastases: case report and review of the literature

  • Case report
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Although intracerebral metastases of malignant melanoma are common, those located in the sellar region and within the pontocerebellar area are extremely rare. Furthermore, to our knowledge, there is no report about melanoma metastasis to the epiphysis published so far. We report here a 46-year-old patient who had metastatic lesions in the sellar region, cerebellopontine area and epiphysial gland, preceded by a primary melanoma at her left shoulder. The diagnosis of sellar metastasis was confirmed histopathologically following a stereotactic biopsy. The patient received whole-brain irradiation therapy combined with chemotherapy. After 10 months, she died from a severe hemorrhage in the cerebellopontine angle. Autopsy findings confirmed melanoma metastases both in the cerebellopontine angle and additionally in the epiphysial gland. To our knowledge, this is the first case of multiple intracranial melanoma metastases including the suprasellar region, the pontocerebellar and epiphysial area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Gonzalez-Martinez J, Hernandez L, Zamorano L et al (2002) Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J Neurosurg 97:494–498

    Article  PubMed  Google Scholar 

  2. Kingdom TT, Lalwani AK, Pitts LH (1993) Isolated metastatic melanoma of the cerebellopontine angle: case report. Neurosurgery 33:142–144. doi:10.1097/00006123-199307000-00024

    Article  PubMed  CAS  Google Scholar 

  3. Morita A, Meyer FB, Laws ER Jr (1998) Symptomatic pituitary metastases. J Neurosurg 89:69–73

    PubMed  CAS  Google Scholar 

  4. Stevens G, Firth I, Coates A (1992) Cerebral metastases from malignant melanoma. Radiother Oncol 23:185–191. doi:10.1016/0167-8140(92)90329-S

    Article  PubMed  CAS  Google Scholar 

  5. Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 28:81–117. doi:10.1016/S0889-8529(05)70058-X

    Article  PubMed  CAS  Google Scholar 

  6. Tarhini AA, Agarwala SS (2004) Management of brain metastases in patients with melanoma. Curr Opin Oncol 16:161–166. doi:10.1097/00001622-200403000-00014

    Article  PubMed  Google Scholar 

  7. Wronski M, Arbit E (2000) Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 93:9–18

    Article  PubMed  CAS  Google Scholar 

  8. Bafaloukos D, Gogas H (2004) The treatment of brain metastases in melanoma patients. Cancer Treat Rev 30:515–520. doi:10.1016/j.ctrv.2004.05.001

    Article  PubMed  CAS  Google Scholar 

  9. Copeland DD, Sink JD, Seigler HF (1980) Primary intracranial melanoma presenting as a suprasellar tumor. Neurosurgery 6:542–545. doi:10.1097/00006123-198005000-00008

    Article  PubMed  CAS  Google Scholar 

  10. Komninos J, Vlassopoulou V, Protopapa D et al (2004) Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89:574–580. doi:10.1210/jc.2003-030395

    Article  PubMed  CAS  Google Scholar 

  11. Leung GK, Chow WS, Tan KC et al (2003) Metastatic melanoma of the pituitary gland. Case report. J Neurosurg 99:913–915

    Article  PubMed  Google Scholar 

  12. Arriaga MA, Lo WW, Brackmann DE (1995) Metastatic melanoma to the cerebellopontine angle. Clinical and imaging characteristics. Arch Otolaryngol Head Neck Surg 2:1052–1056

    Google Scholar 

  13. Delerue O, Destee A, Devos P (1991) Bilateral metastases in the cerebellopontine angle. J Neurol Neurosurg Psychiatry 54:562–563. doi:10.1136/jnnp.54.6.562-a

    Article  PubMed  CAS  Google Scholar 

  14. Roessmann U, Kaufman B, Friede RL (1970) Metastatic lesions in the sella turcica and pituitary gland. Cancer 25:478–480. doi:10.1002/1097-0142(197002)25:2<478::AID-CNCR2820250227>3.0.CO;2-X

    Article  PubMed  CAS  Google Scholar 

  15. Shinogami M, Yamasoba T, Sasaki T (1998) Bilateral isolated metastases of malignant melanoma to the cerebellopontine angle. Otolaryngol Head Neck Surg 118:276–279. doi:10.1016/S0194-5998(98)80031-4

    Article  PubMed  CAS  Google Scholar 

  16. Fassett DR, Couldwell WT (2004) Metastases to the pituitary gland. Neurosurg Focus 16:E8

    PubMed  Google Scholar 

  17. Teears RJ, Silverman EM (1975) Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland. Cancer 36:216–220. doi:10.1002/1097-0142(197507)36:1<216::AID-CNCR2820360123>3.0.CO;2-E

    Article  PubMed  CAS  Google Scholar 

  18. Mayr NA, Yuh WT, Muhonen MG et al (1993) Pituitary metastases: MR findings. J Comput Assist Tomogr 17:432–437. doi:10.1097/00004728-199305000-00018

    Article  PubMed  CAS  Google Scholar 

  19. Nelson PB, Robinson AG, Martinez AJ (1987) Metastatic tumor of the pituitary gland. Neurosurgery 21:941–944. doi:10.1097/00006123-198712000-00030

    Article  PubMed  CAS  Google Scholar 

  20. Rousseau A, Bernier M, Kujas M et al (2005) Primary intracranial melanocytic tumor simulating pituitary macroadenoma: case report and review of the literature. Neurosurgery 57:E369. doi:10.1227/01.NEU.0000166686.19823.A9

    Article  PubMed  Google Scholar 

  21. Sam S, Molitch ME (2005) The pituitary mass: diagnosis and management. Rev Endocr Metab Disord 6:55–62. doi:10.1007/s11154-005-5225-z

    Article  PubMed  Google Scholar 

  22. Chiang MF, Brock M, Patt S (1990) Pituitary metastases. Neurochirurgia (Stuttg) 33:127–131

    CAS  Google Scholar 

  23. Whinney D, Kitchen N, Revesz T et al (2001) Primary malignant melanoma of the cerebellopontine angle. Otol Neurotol 22:218–222. doi:10.1097/00129492-200103000-00018

    Article  PubMed  CAS  Google Scholar 

  24. Mendez IM, Del Maestro RF (1988) Cerebral metastases from malignant melanoma. Can J Neurol Sci 15:119–123

    PubMed  CAS  Google Scholar 

  25. Juneau P, Schoene WC, Black P (1992) Malignant tumors in the pituitary gland. Arch Neurol 49:555–558

    PubMed  CAS  Google Scholar 

  26. McCormick PC, Post KD, Kandji AD et al (1989) Metastatic carcinoma to the pituitary gland. Br J Neurosurg 3:71–79. doi:10.3109/02688698909001028

    Article  PubMed  CAS  Google Scholar 

  27. Tuttenberg J, Fink W, Back W et al (2004) A rare primary sellar melanoma. Case report. J Neurosurg 100:931–934

    Article  PubMed  Google Scholar 

  28. Kaltsas GA, Nomikos P, Kontogeorgos G et al (2005) Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90:3089–3099. doi:10.1210/jc.2004-2231

    Article  PubMed  CAS  Google Scholar 

  29. Benjamin L (1857) Ein Krebsfall. Virchows Arch Path Anat 12:566–569. doi:10.1007/BF01950081

    Article  Google Scholar 

  30. Sioutos P, Yen V, Arbit E (1996) Pituitary gland metastases. Ann Surg Oncol 3:94–99. doi:10.1007/BF02409058

    Article  PubMed  CAS  Google Scholar 

  31. Neilson JM, Moffat AD (1963) Hypopituitarism caused by a melanoma of the pituitary gland. J Clin Pathol 16:144–149. doi:10.1136/jcp.16.2.144

    Article  PubMed  CAS  Google Scholar 

  32. Aubin MJ, Hardy J, Comtois R (1997) Primary sellar haemorrhagic melanoma: case report and review of the literature. Br J Neurosurg 1:80–83

    Google Scholar 

  33. Escott EJ (2001) A variety of appearances of malignant melanoma in the head: a review. Radiographics 21:625–639

    Google Scholar 

  34. Woodruff WW Jr, Djang WT, McLendon RE et al (1987) Intracerebral malignant melanoma: high-field-strength MR imaging. Radiology 165:209–213

    PubMed  Google Scholar 

  35. Chappell PM, Kelly WM, Ercius M (1990) Primary sellar melanoma simulating hemorrhagic pituitary adenoma: MR and pathologic findings. AJNR Am J Neuroradiol 11:1054–1056

    PubMed  CAS  Google Scholar 

  36. Farrokh D, Fransen P, Faverly D (2001) MR findings of a primary intramedullary malignant melanoma: case report and literature review. AJNR Am J Neuroradiol 22:1864–1866

    PubMed  CAS  Google Scholar 

  37. Suzuki M, Takashima T, Kadoya M et al (1993) Signal intensity of brain metastases on T2-weighted images: specificity for metastases from colonic cancers. Neurochirurgia (Stuttg) 36:151–155

    CAS  Google Scholar 

  38. Yuh WT, Mayr-Yuh NA, Koci TM et al (1993) Metastatic lesions involving the cerebellopontine angle. AJNR Am J Neuroradiol 14:99–106

    PubMed  CAS  Google Scholar 

  39. Schubiger O, Haller D (1992) Metastases to the pituitary–hypothalamic axis. An MR study of seven symptomatic patients. Neuroradiology 34:131–134. doi:10.1007/BF00588159

    Article  PubMed  CAS  Google Scholar 

  40. Berman JM, Farkashidy J, Jahn AF et al (1979) Peripheral facial paralysis secondary to metastatic malignant melanoma. A clinicopathologic report. Arch Otolaryngol 105:51–52

    PubMed  CAS  Google Scholar 

  41. Max MB, Deck MD, Rottenberg DA (1981) Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology 31:998–1002

    PubMed  CAS  Google Scholar 

  42. Brackmann DE, Bartels LJ (1980) Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg 88:555–559

    PubMed  CAS  Google Scholar 

  43. Currie L, Tomma A (2001) Malignant melanoma presenting as sudden onset of complete hearing loss. Ann Plast Surg 47:336–337. doi:10.1097/00000637-200109000-00020

    Article  PubMed  CAS  Google Scholar 

  44. Lee WT, Weber PC (2005) Melanoma metastasis masquerading as bilateral acoustic neuromas. Otolaryngol Head Neck Surg 132:505–506. doi:10.1016/j.otohns.2004.05.004

    Article  PubMed  Google Scholar 

  45. Tu AS, Wang H, Harris-McCorkle L et al (1994) Bilateral involvement of the cerebellopontine angles by malignant melanoma metastasis: a case report. Md Med J 43:967–970

    PubMed  CAS  Google Scholar 

  46. Vasdev A, David P, Villemot D et al (1990) Apparently primary malignant melanoma of the cerebellopontine angle. One case. J Neuroradiol 17:152–156

    PubMed  CAS  Google Scholar 

  47. Breger RK, Papke RA, Pojunas KW et al (1987) Benign extraaxial tumors: contrast enhancement with Gd-DTPA. Radiology 163:427–429

    PubMed  CAS  Google Scholar 

  48. Jeong HJ, Chung JK, Kim YK et al (2002) Usefulness of whole-body (18) F-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med 43:1432–1437

    PubMed  Google Scholar 

  49. Reinhardt MJ, Kensy J, Frohmann JP et al (2002) Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data. Nucl Med (Stuttg) 41:143–147

    CAS  Google Scholar 

  50. Kumar R, Mavi A, Bural G et al (2005) Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiol Clin North Am 43:23–33. doi:10.1016/j.rcl.2004.09.011

    Article  PubMed  Google Scholar 

  51. Tilgner J, Herr M, Ostertag C et al (2005) Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis—influence of clinical factors. Neurosurgery 56:257–265. doi:10.1227/01.NEU.0000148899.39020.87

    Article  PubMed  Google Scholar 

  52. Rodriguez y Baena R, Gaetani P et al (1992) Primary solitary intracranial melanoma: case report and review of the literature. Surg Neurol 38:26–37. doi:10.1016/0090-3019(92)90208-5

    Article  PubMed  Google Scholar 

  53. Jawahar A, Shaya M, Campbell P et al (2005) Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (three to six) intracranial metastases. Surg Neurol 64:207–212. doi:10.1016/j.surneu.2005.04.003

    Article  PubMed  Google Scholar 

  54. Sampson JH, Carter JH Jr, Friedman AH et al (1998) Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88:11–20

    PubMed  CAS  Google Scholar 

  55. Mori Y, Kondziolka D, Flickinger JC et al (1998) Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581–589. doi:10.1016/S0360-3016(98)00272-7

    PubMed  CAS  Google Scholar 

  56. Panagiotou IE, Brountzos EN, Kelekis DA et al (2005) Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma 52:150–158

    PubMed  CAS  Google Scholar 

  57. Ferraresi V, Ciccarese M, Zeuli M et al (2005) Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two cases. Melanoma Res 15:467–469. doi:10.1097/00008390-200510000-00017

    Article  PubMed  Google Scholar 

  58. Sharpless SM, Das Gupta TK (1998) Surgery for metastatic melanoma. Semin Surg Oncol 14:311–318. doi:10.1002/(SICI)1098-2388(199806)14:4<311::AID-SSU7>3.0.CO;2-5

    Article  PubMed  CAS  Google Scholar 

  59. Fernandez E, Maira G, Puca A et al (1984) Multiple intracranial metastases of malignant melanoma with long-term survival. Case report. J Neurosurg 60:621–624

    Article  PubMed  CAS  Google Scholar 

  60. Zacest AC, Besser M, Stevens G et al (2002) Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96:552–558

    Article  PubMed  Google Scholar 

  61. Konstadoulakis MM, Messaris E, Zografos G et al (2000) Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases. Is there a role for surgery? J Neurosurg Sci 44:211–218

    PubMed  CAS  Google Scholar 

  62. Meier S, Baumert BG, Maier T et al (2004) Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 27:145–149. doi:10.1159/000076903

    Article  PubMed  CAS  Google Scholar 

  63. Hofmann M, Kiecker F, Wurm R et al (2006) Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 76:59–64. doi:10.1007/s11060-005-2914-0

    Article  PubMed  CAS  Google Scholar 

  64. Hwu WJ, Lis E, Menell JH et al (2005) Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. Cancer 103:2590–2597. doi:10.1002/cncr.21081

    Article  PubMed  CAS  Google Scholar 

  65. Jacquillat C, Khayat D, Banzet P et al (1990) Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma. Cancer Chemother Pharmacol 25:263–266. doi:10.1007/BF00684883

    Article  PubMed  CAS  Google Scholar 

  66. Fife KM, Colman MH, Stevens GN et al (2004) Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22:1293–1300. doi:10.1200/JCO.2004.08.140

    Article  PubMed  CAS  Google Scholar 

  67. Petrovich Z, Yu C, Giannotta SL et al (2002) Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 97:499–506

    PubMed  Google Scholar 

  68. Retsas S, Gershuny AR (1988) Central nervous system involvement in malignant melanoma. Cancer 61:1926–1934. doi:10.1002/1097-0142(19880501)61:9<1926::AID-CNCR2820610934>3.0.CO;2-I

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr. Aslan Güzel is supported by TUBITAK (Scientific and Technical Research Council of Turkey) and DFG (Deutsche Forschungsgemeinschaft). The authors would like to thank Mrs. Donata Maciaczyk for her contribution in preparing the figures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aslan Guzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guzel, A., Maciaczyk, J., Dohmen-Scheufler, H. et al. Multiple intracranial melanoma metastases: case report and review of the literature. J Neurooncol 93, 413–420 (2009). https://doi.org/10.1007/s11060-008-9785-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9785-0

Keywords

Navigation